Notman Donald's Form 4 filing
Ocular Therapeutix, Inc (OCUL) · filed Feb 4, 2026
- Accession no.
- 0001104659-26-010462
- Filed
- Feb 4, 2026
- Trade date
- Feb 2-4, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $101.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Notman DonaldCIK 0001718019 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Common Stock | SSaleDisposed | −5,455 | $9.14 | −$49,858.7 | 383,837 | Direct | |
| Feb 4, 2026 | Common Stock | SSaleDisposed | −6,035 | $8.54 | −$51,538.9 | 377,802 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.